Clinical Trials Directory

Trials / Completed

CompletedNCT03769857

NEM® + BIOCURC® Versus Placebo in Exercised-induced Joint Pain, Stiffness, & Cartilage Turnover in Healthy Men & Women

Efficacy of NEM® Brand Eggshell Membrane Plus BIOCURC® Brand Bioavailable Curcumin Versus Placebo in Exercised-induced Joint Pain, Stiffness, & Cartilage Turnover in Healthy Men & Women

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
84 (actual)
Sponsor
ESM Technologies, LLC · Industry
Sex
All
Age
40 Years – 75 Years
Healthy volunteers
Accepted

Summary

This study is intended to evaluate the combined effects of the dietary supplement NEM® brand eggshell membrane and BIOCURC® brand bioavailable curcumin versus placebo in reducing exercise-induced joint pain, stiffness \& cartilage turnover in healthy men \& women. Half of the study participants will receive NEM+BIOCURC, once daily, orally while the other half of the study participants will receive placebo, once daily, orally while performing an exercise regimen every other day for two weeks.

Detailed description

Moderate exercise can induce discomfort in joints when done infrequently or when done too intensely or for too long a period. This discomfort is often realized as either pain or stiffness in the joint that was the focus of the exercise. For example, one's knees will hurt after jogging for several miles, particularly if jogging for the first time. This study is intended to evaluate whether the combination of NEM® brand eggshell membrane and BIOCURC® brand bioavailable curcumin can alleviate joint pain or stiffness, either directly following exercise or 12 hours post-exercise versus placebo. The study will also evaluate the combination's effect, on cartilage turnover via the cartilage degradation biomarker c-terminal cross-linked telopeptide of type II collagen (CTX-II). Participants will perform a minimum of 50 steps per leg utilizing an aerobics step at the clinical site. They will follow this exercise regimen on alternating days for 2 consecutive weeks. Changes in pain \& stiffness (immediate \& 12-hour) will be compared to both baseline and to the placebo group. Urine samples will also be collected at baseline and at the end of Week 1 \& Week 2. The change in CTX-II from baseline will be compared to the placebo group.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTNEM® + BIOCURC®Dietary supplement combination for the support of joint health.
DIETARY_SUPPLEMENTPlaceboPlacebo

Timeline

Start date
2019-01-13
Primary completion
2019-02-20
Completion
2019-04-15
First posted
2018-12-10
Last updated
2019-07-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03769857. Inclusion in this directory is not an endorsement.